These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6228358)

  • 1. Defective chemotactic factor-induced monocyte complement receptor enhancement in lung cancer.
    Carroll M; Lukacs K; Hodson M; Kay AB
    Clin Exp Immunol; 1983 Dec; 54(3):785-92. PubMed ID: 6228358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor associated defects of cultured monocytes in bronchial carcinoma.
    Lukacs K; Carroll MP; Hodson ME; Kay AB
    Clin Exp Immunol; 1984 May; 56(2):321-9. PubMed ID: 6733974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of human monocyte complement (C3b) receptors by chemoattractants.
    Glass EJ; Kay AB
    Clin Exp Immunol; 1980 Mar; 39(3):768-75. PubMed ID: 7379336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of monocyte complement receptor enhancement by low molecular weight material from human lung cancers.
    Glass EJ; Abell CA; Kay AB
    Clin Exp Immunol; 1981 Mar; 43(3):540-8. PubMed ID: 7285392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucoattractants enhance complement receptors on human phagocytic cells.
    Kay AB; Glass EJ; Salter DM
    Clin Exp Immunol; 1979 Nov; 38(2):294-9. PubMed ID: 527263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of human neutrophil complement receptors: a comparison of the rosette technique with the uptake of radio-labelled anti-CR1 monoclonal antibody.
    Richerson HB; Walsh GM; Walport MJ; Moqbel R; Kay AB
    Clin Exp Immunol; 1985 Nov; 62(2):442-8. PubMed ID: 3936652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monocyte function test (complement receptor enhancement) to assess the extent of bronchial carcinoma.
    Carroll M; Smith MJ; Hodson ME; Kay AB
    Thorax; 1987 Jan; 42(1):53-8. PubMed ID: 3616973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood monocyte function in leprosy patients.
    Masuda A; Scheinberg MA
    Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):254-9. PubMed ID: 7192267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid-resistant chronic asthma and monocyte complement receptors.
    Kay AB; Diaz P; Carmicheal J; Grant IW
    Clin Exp Immunol; 1981 Jun; 44(3):576-80. PubMed ID: 7326867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of complement in adherent immune complexes on Fc and C3 receptor expression in human monocytes.
    Arend WP; Massoni RJ
    Immunology; 1981 Dec; 44(4):717-25. PubMed ID: 7319557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of the C5a receptor and complement receptors 1 and 3 after LPS stimulation of neutrophils and monocytes.
    Furebring M; Håkansson L; Venge P; Sjölin J
    Scand J Immunol; 2004 Nov; 60(5):494-9. PubMed ID: 15541042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte chemotactic factors and the C3b receptor.
    Kay AB; Duncan AJ; Glass EJ; Stewart J
    Kroc Found Ser; 1981; 14():197-211. PubMed ID: 6458667
    [No Abstract]   [Full Text] [Related]  

  • 13. Monocyte functions in patients with mixed connective tissue disease.
    Bodolay E; Lukács K; Szabó G; Frendl G; Ben T; Szegedi G
    Allergol Immunopathol (Madr); 1989; 17(1):39-43. PubMed ID: 2526572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytosis by human monocyte-derived macrophages. Independent function of receptors for C3b (CR1) and iC3b (CR3).
    Newman SL; Devery-Pocius JE; Ross GD; Henson PM
    Complement; 1984; 1(4):213-27. PubMed ID: 6242391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils.
    Beswick PH; Kay AB
    Clin Exp Immunol; 1981 Feb; 43(2):399-407. PubMed ID: 6268337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of the potent neutrophil chemokine, growth-related protein alpha (GROalpha), is not elevated in cystic fibrosis children.
    Wyatt HA; Sampson AP; Balfour-Lynn IM; Price JF
    Respir Med; 2000 Feb; 94(2):106-11. PubMed ID: 10714414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of IgG and complement receptor expression of phagocytes in kidney cancer patients during treatment with interferon-alpha.
    Salminen E; Kankuri M; Nuutila J; Lilius EM; Pellimiemi TT
    Anticancer Res; 2001; 21(3B):2049-55. PubMed ID: 11497297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Nickel Oxide (CAS No. 1313-99-1) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Jul; 451():1-381. PubMed ID: 12594524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of neutrophil- and eosinophil-mediated complement-dependent killing of schistosomula of Schistosoma mansoni in vitro by leukotriene B4.
    Moqbel R; Sass-Kuhn SP; Goetzl EJ; Kay AB
    Clin Exp Immunol; 1983 Jun; 52(3):519-27. PubMed ID: 6307558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.